846 related articles for article (PubMed ID: 19273710)
41. [General rules for the study of pancreatic cancer by molecular biological aspect].
Omata M; Tada M
Nihon Geka Gakkai Zasshi; 2000 Feb; 101(2):233-6. PubMed ID: 10734643
[TBL] [Abstract][Full Text] [Related]
42. Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.
Maitra A; Molberg K; Albores-Saavedra J; Lindberg G
Am J Pathol; 2000 Oct; 157(4):1105-11. PubMed ID: 11021814
[TBL] [Abstract][Full Text] [Related]
43. KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma.
Sinn BV; Striefler JK; Rudl MA; Lehmann A; Bahra M; Denkert C; Sinn M; Stieler J; Klauschen F; Budczies J; Weichert W; Stenzinger A; Kamphues C; Dietel M; Riess H
Pancreas; 2014 May; 43(4):578-83. PubMed ID: 24681874
[TBL] [Abstract][Full Text] [Related]
44. [New molecular targets in pancreatic cancer].
Torrisani J; Bournet B; Cordelier P; Buscail L
Bull Cancer; 2008 May; 95(5):503-12. PubMed ID: 18541514
[TBL] [Abstract][Full Text] [Related]
45. Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis.
Betge J; Pollheimer MJ; Schlemmer A; Hoefler G; Langner C
Oncol Rep; 2011 Sep; 26(3):567-75. PubMed ID: 21687951
[TBL] [Abstract][Full Text] [Related]
46. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
[TBL] [Abstract][Full Text] [Related]
47. Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomas.
Bartsch D; Barth P; Bastian D; Ramaswamy A; Gerdes B; Chaloupka B; Deiss Y; Simon B; Schudy A
Cancer Lett; 1999 May; 139(1):43-9. PubMed ID: 10408907
[TBL] [Abstract][Full Text] [Related]
48. Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method.
Rückert F; Aust D; Böhme I; Werner K; Brandt A; Diamandis EP; Krautz C; Hering S; Saeger HD; Grützmann R; Pilarsky C
J Surg Res; 2012 Jan; 172(1):29-39. PubMed ID: 21683373
[TBL] [Abstract][Full Text] [Related]
49. [Advance in the biology of pancreatic of cancer].
Buscail L; Bournet B; Dufresne M; Torrisani J; Cordelier P
Bull Cancer; 2015 Jun; 102(6 Suppl 1):S53-61. PubMed ID: 26118878
[TBL] [Abstract][Full Text] [Related]
50. Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.
Fralix KD; Ahmed MM; Mattingly C; Swiderski C; McGrath PC; Venkatasubbarao K; Kamada N; Mohiuddin M; Strodel WE; Freeman JW
Cancer; 2000 May; 88(9):2010-21. PubMed ID: 10813711
[TBL] [Abstract][Full Text] [Related]
51. Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4.
Masetti M; Acquaviva G; Visani M; Tallini G; Fornelli A; Ragazzi M; Vasuri F; Grifoni D; Di Giacomo S; Fiorino S; Lombardi R; Tuminati D; Ravaioli M; Fabbri C; Bacchi-Reggiani ML; Pession A; Jovine E; de Biase D
Cancer Biomark; 2018 Feb; 21(2):323-334. PubMed ID: 29103024
[TBL] [Abstract][Full Text] [Related]
52. Molecular pathobiology of pancreatic adenocarcinoma.
Mangray S; King TC
Front Biosci; 1998 Nov; 3():D1148-60. PubMed ID: 9820739
[TBL] [Abstract][Full Text] [Related]
53. p53 and DPC4 alterations in the bile of patients with pancreatic carcinoma.
Pantalone D; Pelo E; Minuti B; Giotti I; Mazza E; Falchini M; Neri B; Nesi G; Roberta Girardi L; Pulli R; Credi G; Torricelli F
J Surg Oncol; 2004 Dec; 88(4):210-6. PubMed ID: 15565642
[TBL] [Abstract][Full Text] [Related]
54. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
[TBL] [Abstract][Full Text] [Related]
55. A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway.
Holloway S; Davis M; Jaber R; Fleming J
Int J Gastrointest Cancer; 2003; 33(1):61-9. PubMed ID: 12909738
[TBL] [Abstract][Full Text] [Related]
56. Pathogenesis of multiple pancreatic cancers involves multicentric carcinogenesis and intrapancreatic metastasis.
Fujita Y; Matsuda S; Sasaki Y; Masugi Y; Kitago M; Yagi H; Abe Y; Shinoda M; Tokino T; Sakamoto M; Kitagawa Y
Cancer Sci; 2020 Feb; 111(2):739-748. PubMed ID: 31799787
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis.
Wang JD; Jin K; Chen XY; Lv JQ; Ji KW
Oncotarget; 2017 Mar; 8(10):16704-16711. PubMed ID: 28053288
[TBL] [Abstract][Full Text] [Related]
58. EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung.
Jia XL; Chen G
Lung Cancer; 2011 Dec; 74(3):396-400. PubMed ID: 21592614
[TBL] [Abstract][Full Text] [Related]
59. Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas.
Wang R; Pan Y; Li C; Zhang H; Garfield D; Li Y; Ye T; Hu H; Luo X; Li H; Zhang Y; Zhang J; Zhou X; Shen L; Pao W; Sun Y; Chen H
J Thorac Oncol; 2014 Jun; 9(6):760-8. PubMed ID: 24481316
[TBL] [Abstract][Full Text] [Related]
60. BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Pathol Int; 2013 Mar; 63(3):176-82. PubMed ID: 23530562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
